Great Novel Therapeutics Biotech & Medicals Corporation
2 clinical trials · Sponsor
◉ Watch Great Novel Therapeutics Biotech & Medicals Corporation
| Record | Firm | Date |
|---|---|---|
| Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL) (NCT05833724) | Great Novel Therapeutics Biotech & Medicals Corporation | 2024-10-18 |
| Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC) (NCT05770882) | Great Novel Therapeutics Biotech & Medicals Corporation | 2023-04-25 |
Track Great Novel Therapeutics Biotech & Medicals Corporation automatically
Every clearance here is in the API, with alerts when new ones post.